Further observations on the immune response to recombinant hepatitis B vaccine after administration to Aboriginal and Torres Strait Island children

Journal of Paediatrics and Child Health

Volumn 33, Issue 1, 1997, Pages 67-70

  Hanna, J N ^a,c   Faoagali, J L ^b   Buda, P J ^b   Sheridan, J W ^c  

^a TROPICAL PUBLIC HEALTH UNIT   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c QUEENSLAND HEALTH   (Australia)

Author keywords

Aboriginal and Torres Strait Island children; hepatitis B; vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ABORIGINE; ARTICLE; AUSTRALIA; FEMALE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY;

EID: 0031058822     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb00994.x     Document Type: Article

References (23)

1. Thomson N, Honari M. A review of hepatitis B. infection among Aborigines. Aboriginal Health Information Bull. 1988; 9: 24-8.
2. Sheridan J, Donald K, Jameson J. The Queensland hepatitis B. program. Aboriginal Health Information Bull. 1989; 12: 19-23.
3. Gardner I, Wan X. Mathews J. Hepatitis B in Aboriginal Australians. Today's Life Sci. 1990; 2: 16-22.
4. Hanna JN, Sexton WL, Faoagali JL et al. Immunity to hepatitis B, poliomyelitis and measles in fully vaccinated Aboriginal and Torres Strait Island children. J. Paediatr Child Health 1995; 31: 345-9.
5. National Health and Medical Research Council. Immunisation Procedures, 3rd edn. Australian Government Publishing Service, Canberra., 1986; 56-62.
6. Dean AG, Dean JA, Coulombier D et al. Epi Info, Version 6: a work processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, USA, 1994.
7. Armitage P, Berry G. Statistical methods in medical research. 2nd edn. Blackwell Science, Oxford, 1987; 117.
8. Don C-J, Lim G-K, Ye Z et al. Molecular epidemiology of hepatitis B virus variants in Singapore. Vaccine 1995; 13: 699-702.
9. Fortuin M, Karthegisu V, Allison L et al. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J. Infect. Dis. 1994; 169: 1374-6.
10. Moyes CD, Milne A, Waldon J. Very low dose hepatitis B vaccination in the newborn: Anamnestic response to booster at four years. J. Med. Virol. 1990; 30: 216-8.
11. Milne A, Krugman S, Waldon JA et al. Hepatitis B vaccination in children: Five year booster study. NZ Med. J. 1992; 105: 336-8.
12. Lau Y-L, Tam AYC, Ng KW et al. Responses of preterm infants to hepatitis B vaccine. J. Pediatr. 1992; 121: 962-5.
13. Charwareewong S, Jirapongsa A, Lokaphadhana K. Immune response to hepatitis B vaccine in premature infants. Southeast Asian J. Trop. Med. Public Health 1991; 22: 39-40.
14. Thurz MR, Kwiatowski D, Allsopp CEM et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 1995; 332: 1065-9.
15. Alper CA, Kruskall MS, Marcus-Bagley D et al. Genetic prediction of nonresponse to hepatitis B vaccine. N. Engl. J. Med. 1989; 321: 708-12.
16. Roome AJ, Walsh SJ, Cartter ML et al. Hepatitis B vaccine responsiveness in Connecticut public safey personnel. JAMA 1993; 270: 2931-2934.
17. Winter AP, Follett AC, McIntyre J et al. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine 1994; 12: 771-72.
18. Guest CS, O'Dea K, Carlin JB, Larkins RG. Smoking in Aborigines and persons of European descent in southeastern Australia: Prevalence and associations with food habits, body fat distribution and other cardiovascular risk factors. Aust. J. Public Health 1992; 16: 397-402.
19. Deinhardt F, Zuckerman AJ. Immunisation against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. J. Med. Virol. 1985; 17: 209-17.
20. Peterson NJ, Barrett DH, Bond WW et al. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl. Environ. Microbiol. 1976; 32: 572-4.
21. Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among Aboriginal children. J. Paediatr. Child Health 1995; 31: 245-8.
22. Yap I, Guan R, Chan SH. Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines. J. Gastroenterol. Hepatol. 1995; 10: 51-5.
23. Raz R, Dagan R, Gallil A, Brill G, Kassis I, Koren R. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children. Vaccine 1996; 14: 207-11.